How to Help Your Patients Save Money on Prucalopride: A Provider's Guide to Savings Programs

Medication cost is one of the most common reasons patients abandon effective treatments for chronic idiopathic constipation (CIC). Before the generic prucalopride launched in January 2025, brand-name Motegrity cost $550–$735 per month without insurance — a price point that caused many patients to discontinue or never start treatment. This guide helps providers navigate the full cost landscape and support their patients in accessing prucalopride affordably.

The Cost Landscape in 2026: Brand vs. Generic

Understanding what patients will actually pay starts with knowing the current price landscape:

• Brand-name Motegrity (2 mg, 30 tablets): Retail: $550–$735 without insurance. With Takeda Savings Card (commercially insured patients): may reduce significantly. With GoodRx brand coupon: approximately $553.
• Generic prucalopride (2 mg, 30 tablets): Retail without coupon: approximately $509–$517. With GoodRx Gold coupon: as low as $26.79. With SingleCare coupon: approximately $37.60.

The practical implication: most patients without insurance (or with non-covering insurance) should be steered to the generic with a GoodRx-type coupon. The difference between retail generic ($509) and coupon generic ($27–$38) is dramatic, and most patients don't know about coupon programs unless their provider or pharmacist tells them.

Prescribing Strategy: Always Prescribe Generic to Maximize Options

Writing prescriptions for "prucalopride" (the generic name) rather than "Motegrity" ensures patients can access whichever form their pharmacy has — brand or generic — and qualify for generic coupon programs. Avoid Dispense as Written (DAW) codes unless there is a specific clinical reason to require the brand.

When patients ask about the generic, reassure them that FDA-approved generic prucalopride has undergone bioequivalence testing and meets the same standards for safety and efficacy as the brand.

Takeda Motegrity Savings Card

Takeda Pharmaceuticals offers a Savings Card for brand-name Motegrity for eligible commercially insured patients. Patients can inquire at 1-844-447-2582. This program is designed to reduce copay burden for patients whose insurance covers Motegrity but with a high Tier 3–4 copay.

Key limitations to communicate to patients:

• Not available for Medicare or Medicaid patients
• May not apply if the drug isn't covered by insurance (patient pays out-of-pocket)
• Eligibility criteria and savings amounts may change — verify current program details at the Motegrity website or by calling the number above

Prescription Discount Programs (GoodRx, SingleCare, NeedyMeds)

For patients paying out of pocket — whether uninsured, underinsured, or on Medicare without Part D coverage — prescription discount programs are the most powerful cost-reduction tool:

• GoodRx: Generic prucalopride as low as $26.79/month with GoodRx Gold; free basic membership also provides major savings. Available at goodrx.com or the GoodRx app.
• SingleCare: Generic prucalopride approximately $37.60/month. Available at singlecare.com.
• NeedyMeds.org: Free search tool for patient assistance programs — useful for uninsured or low-income patients who may qualify for free or deeply discounted medication directly from the manufacturer.

Consider printing or displaying a GoodRx QR code in your office. Patients often don't know about these programs. A brief mention at the point of prescribing — "If your insurance doesn't cover this, use GoodRx for the generic; it's about $27 a month" — can prevent abandonment and improve adherence.

Prior Authorization: Building the Strongest Possible Case

For patients whose insurance covers prucalopride but requires prior authorization, the quality of your documentation determines whether the PA is approved on the first submission. A strong PA request for prucalopride should include:

1. ICD-10 diagnosis code for CIC (K59.00 or K59.09) with confirmed duration ≥ 3 months
2. Documentation of failed OTC laxative trials (name, dose, duration, response) — typically 4–8 weeks
3. Documentation of failed or contraindicated preferred agents (usually linaclotide/Linzess; sometimes plecanatide/Trulance)
4. Clinical rationale for prucalopride's specific mechanism (e.g., slow-transit constipation where prokinetic therapy is more appropriate than secretagogue)
5. Renal function documentation if relevant to dosing justification

Medicare Patients: Special Considerations

Most Medicare Part D plans do not cover Motegrity, and generic prucalopride coverage varies by plan. For Medicare patients, the practical options are:

• Generic prucalopride with GoodRx coupon (~$27/month) — often the best overall option for Medicare patients without Part D coverage
• Check specific Part D plan formulary — some Medicare Advantage plans may cover generic prucalopride at Tier 3–4; coverage improved with the generic launch
• NeedyMeds patient assistance programs for low-income Medicare patients who can't afford even the generic

HSA and FSA: Remind Patients They Can Use Pre-Tax Funds

Patients with employer-sponsored HSA or FSA accounts can use pre-tax funds for prucalopride, effectively providing a 22–37% tax-based discount depending on their income bracket. This is an underused resource. A brief mention at prescribing — especially for patients who are paying out of pocket — can meaningfully reduce their effective cost.

Practice-Level Implementation: A Sample Script

When prescribing prucalopride, consider a brief cost conversation at the visit:

"I'm prescribing generic prucalopride. If your insurance covers it, great — check your copay. If not, or if it's expensive, use GoodRx on your phone; the generic is about $27 a month with their coupon. If you have a savings account through work (HSA or FSA), you can use that too. Call my office if you run into problems getting it filled."

For patients who struggle to find prucalopride in stock, medfinder can help by calling pharmacies near them and texting back which ones have it in stock — reducing patient callbacks to your office.